Periodic Reporting for period 2 - residualCRC (MECHANISMS BEHIND RESIDUAL DISEASE IN COLORECTAL CANCER and MODELLING OF THERAPIES THAT PREVENT RELAPSE)

Surgical removal of the primary tumor is part of the standard of care for patients with stage I-III colorectal cancer (CRC). However, despite this treatment, 30-40% of these patients undergo metastatic relapse in the following years, which is a significant cause of death...